or Try an Advanced Search...

    Technical Analysis for ENSC - Ensysce Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 0.56 -0.59% 0.00
    ENSC closed down 2.04 percent on Wednesday, May 8, 2024, on 69 percent of normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ENSC trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion -0.61%
    Boomer Sell Setup Bearish Swing Setup -2.64%
    NR7 Range Contraction -2.64%
    Inside Day Range Contraction -2.64%
    Wide Bands Range Expansion -2.64%
    Gapped Up Strength -2.64%
    Boomer Sell Setup Bearish Swing Setup -1.47%
    Inside Day Range Contraction -1.47%
    Wide Bands Range Expansion -1.47%
    Gapped Up Strength -1.47%
    Older End-of-Day Signals for ENSC ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 1 hour ago
    Up 2% about 1 hour ago
    Down 1% about 2 hours ago
    Up 1% about 2 hours ago
    60 Minute Opening Range Breakdown about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ENSC Chart by TradingView
    Basic chart:

    Profile

    Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Health Sciences Pain Pharmacy Psychoactive Drugs Opioids Heroin Morphine Drug Culture Opioid Use Disorder

    Is ENSC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine
    Apr 19 Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published
    Apr 9 Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
    Mar 15 Ensysce Biosciences reports Q4 results
    Mar 15 ENSC Striding Toward Opioid Replacement
    Mar 15 Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results
    Feb 27 Ensysce Biosciences Receives Positive Nasdaq Listing Determination
    Feb 21 Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection
    Feb 16 ENSC: Investors Should Pay Attention
    Feb 15 Ensysce Biosciences Announces Publication of Clinical Bioequivalence Manuscript
    See more ENSC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.58
    52 Week Low 0.53
    Average Volume 136,257
    200-Day Moving Average 1.19
    50-Day Moving Average 0.72
    20-Day Moving Average 0.60
    10-Day Moving Average 0.58
    Average True Range 0.05
    RSI (14) 34.21
    ADX 32.66
    +DI 9.18
    -DI 19.19
    Chandelier Exit (Long, 3 ATRs) 0.63
    Chandelier Exit (Short, 3 ATRs) 0.69
    Upper Bollinger Bands 0.72
    Lower Bollinger Band 0.48
    Percent B (%b) 0.33
    BandWidth 39.75
    MACD Line -0.05
    MACD Signal Line -0.06
    MACD Histogram 0.0068
    Fundamentals Value
    Market Cap 1.77 Million
    Num Shares 3.15 Million
    EPS -1.86
    Price-to-Earnings (P/E) Ratio -0.30
    Price-to-Sales 1.15
    Price-to-Book 2.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.63
    Resistance 3 (R3) 0.63 0.61 0.62
    Resistance 2 (R2) 0.61 0.60 0.61 0.61
    Resistance 1 (R1) 0.59 0.59 0.58 0.58 0.61
    Pivot Point 0.57 0.57 0.56 0.57 0.57
    Support 1 (S1) 0.54 0.55 0.53 0.54 0.51
    Support 2 (S2) 0.52 0.54 0.52 0.51
    Support 3 (S3) 0.50 0.52 0.50
    Support 4 (S4) 0.49